The Life Sciences industry in Australia will be hit disproportionately hard by proposed changes to the R&D Tax Incentive, putting smaller companies at risk and threatening the sector’s ability...
Close
Want to know how this story ends?
Become a subscriber for complete access to all stories on InnovationAus.com and our daily newsletter.